DataMeds AI and Tollo Health have joined forces with the National Football League Alumni Association, through its health branch Alumni Health, to launch a nationwide health initiative dubbed Health Lives Here. The collaboration is set to enhance accessibility to healthcare information, pharmacy services, and health management tools, with a particular focus on underserved and rural areas. By utilizing DataMeds AI’s extensive network of over 6,500 independent pharmacies, the campaign aims to promote healthy living and provide consumers with access to discounted pharmacy services and other crucial healthcare resources.
A central component of this initiative is the Health Lives Here mobile application, which is being developed to function as a consumer-centric telehealth and health management platform. This app is anticipated to enable users to streamline their electronic health records and integrate data from wearable devices into a unified health dashboard. Additionally, the platform will offer access to pharmacy-based services and selected healthcare products, thus empowering users with comprehensive health management tools.
The Health Lives Here initiative was unveiled to professional football alumni during the 2026 Football Hall of Fame Game weekend held in Canton, Ohio. Following this introduction, a broader public rollout is slated to commence in North Carolina in September 2026. Further details regarding the mobile application, participating pharmacies, and the campaign’s expansion will be disclosed in due course.
This partnership brings together Tollo Health’s expertise in medical food and nutraceutical products with DataMeds AI’s advanced healthcare technology and robust pharmacy infrastructure. In addition, the NFL Alumni Association’s health network will play a critical role in reaching out to communities and former professional football players, thereby ensuring the initiative’s widespread impact.
For media inquiries, James Lambert, Vice President at Rubenstein Public Relations, can be reached at 212-805-3024 or via email at [email protected]. For investor-related questions, contact Investor Relations at [email protected]. More information is available on their website, https://datamedsai.com/.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.